BZAM — Bzam Share Price
0.000.00%
Last trade - 00:00HealthcareSpeculativeMicro Cap
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | n/a | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -161.59% | ||
| Return on Equity | -109.73% | ||
| Operating Margin | -191.79% | ||
Financial Summary
| Year End 31st Dec | Unit | 2018 | 2019 | 2020 | 2021 | 2022 | 2023E | 2024E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | CA$m | 1.88 | 10.96 | 12.74 | 30.24 | 49.35 | 99.4 | 120.5 | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
BZAM Ltd. is a Canadian cannabis producer with a focus on branded consumer goods. The Company's portfolio includes core brands, such as BZAM, TGOD, ness, Highly Dutch Organic, TABLE TOP, as well as partner brands Jeeter, Cookies, Sherbinskis, Dunn Cannabis, FRESH and Wyld. It operates facilities in British Columbia (BC), Alberta (AB), Ontario and Quebec, as well as retail stores in Regina, Saskatchewan. The Company’s subsidiaries, The Green Organic Dutchman Ltd. (TGOD), BZAM Management Inc., Folium Life Science Inc. and BZAM Cannabis Corp., are licensed producers and hold licenses to produce cannabis plants, cannabis plant seeds, dried cannabis, fresh cannabis, cannabis oils, cannabis topicals, cannabis extracts and edible cannabis and sell such cannabis products within Canada to provincially authorized retailers or distributors and federally licensed entities. Its product portfolio includes categories, such as Infused, Multi-packs, Edibles, Organic, and Craft.
Directors
- Angus Footman CHM
- Sean Bovingdon CEO (54)
- Nichola Thompson CFO
- Michel Gagne COO
- Matthew Schmidt EVP
- Drew Campbell VPR
- Gayle Duncan OTH
- Rosanna Mastropietro SEC
- Marc Bertrand IND (53)
- Jacques Dessureault IND (57)
- Adam Jaffe IND (30)
- Nicholas Kirton IND (76)
- Caroline MacCallum IND (39)
- Chris Schnarr IND
- Louis Sterling IND
- Last Annual
- December 31st, 2022
- Last Interim
- September 30th, 2023
- Incorporated
- November 16th, 2016
- Public Since
- May 2nd, 2018
- No. of Employees
- 322
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- Canadian Securities Exchange
- Shares in Issue
- 180,818,952
- Address
- 19100 Airport Way, Unit 518, PITT MEADOWS, V3Y 0E2
- Web
- https://bzam.com/
- Phone
- +1 9053044201
- Auditors
- KPMG LLP
Upcoming Events for BZAM
BZAM Ltd Annual Shareholders Meeting
Q3 2024 BZAM Ltd Earnings Release
Similar to BZAM
1933 Industries
Canadian Securities Exchange
1CM
Canadian Securities Exchange
Acreage Holdings
Canadian Securities Exchange
Adastra Holdings
Canadian Securities Exchange
Aion Therapeutic
Canadian Securities Exchange
FAQ
What is the Bzam share price?
As of Today at 19:44 UTC, shares in Bzam are trading at CA$0.03. This share price information is delayed by 15 minutes.
How has the Bzam share price performed this year?
Shares in Bzam last closed at CA$0.03 and the price had moved by -91.67% over the past 365 days. In terms of relative price strength the Bzam share price has underperformed the Toronto Stock Exchange 300 Composite Index by -92.66% over the past year.
What are the analyst and broker recommendations for Bzam?
The overall consensus recommendation for Bzam is Strong Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Bzam dividend yield?
Bzam does not currently pay a dividend.
Does Bzam pay a dividend?
Bzam does not currently pay a dividend.
When does Bzam next pay dividends?
Bzam does not currently pay a dividend.
How do I buy Bzam shares?
To buy shares in Bzam you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Bzam?
As of the previous close price of CA$0.03, shares in Bzam had a market capitalisation of .
Where are Bzam shares listed?
Here are the trading details for Bzam:
- Country of listing: Canada
- Exchange: CNX
- Ticker Symbol: BZAM
What kind of share is Bzam?
Based on an overall assessment of its quality, value and momentum Bzam is currently classified as a . The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Bzam share price forecast for 2024?
We could not find analyst target price data for this security.
Find out moreWhat is the trend in the Bzam share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Bzam. Over the past six months, its share price has underperformed the Toronto Stock Exchange 300 Composite Index by -87.09%.
As of the last closing price of CA$0.03, shares in Bzam were trading matched their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Bzam PE Ratio?
The Bzam PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at CA$0.03.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Bzam?
Bzam's management team is headed by:
- Angus Footman - CHM
- Sean Bovingdon - CEO
- Nichola Thompson - CFO
- Michel Gagne - COO
- Matthew Schmidt - EVP
- Drew Campbell - VPR
- Gayle Duncan - OTH
- Rosanna Mastropietro - SEC
- Marc Bertrand - IND
- Jacques Dessureault - IND
- Adam Jaffe - IND
- Nicholas Kirton - IND
- Caroline MacCallum - IND
- Chris Schnarr - IND
- Louis Sterling - IND